cefaclor

Objective : Determination of the content of cefaclor in oral suspension .

目的：测定头孢克洛混悬液的含量。

Determination of Content of Cefaclor by Using HPLC

HPLC法测定头孢克洛颗粒剂含量

The Factors Influencing on Cefaclor Release From Sustained Release Tablets

影响头孢克罗缓释片释药因素的研究

Optimum Formula of Compound Cefaclor by Orthogonal Design

复方头孢克洛胶囊处方的优选

The efficacy of cefaclor in treatment of diabetes combined with acute cystitis

新达罗治疗糖尿病合并急性膀胱炎42例

Group B was treated with cefaclor 0.5g three times daily for 7 days .

B组用头孢克洛05g，3次/d，共1周；

Efficacy of cefaclor in treating children with secretory otitis media

希刻劳混悬颗粒剂治疗儿童分泌性中耳炎

Studies on Pharmacokinetics and Relative Bioavailability of Two Kinds of Cefaclor Capsule in Healthy Volunteers

2种头孢克罗胶囊的人体药代动力学及相对生物利用度研究

Conclusion Treating the urinary tract infections with cefaclor capsules is safe and effectively .

结论用头孢克洛胶囊治疗尿路感染安全有效，疗效明显优于对照组。

Clinical Effect of Cefaclor on Bronchopneumonia in Children

头孢克罗治疗小儿支气管肺炎的临床观察

Relative Bioavailability of Domestic Cefaclor Capsule in Healthy Volunteers

国产头孢克罗胶囊剂的人体相对生物利用度研究

Objective : To establish capillary electrophoretic method for the separation and determination of cefaclor in human urine .

目的：建立适合国人尿液中头孢克洛分离分析的毛细管电泳方法。

In Vitro and in Vivo Antibacterial Activities of Cefaclor

头孢克洛的体外与体内抗菌作用研究

Objective : To observe the efficacy of domestic and imported cefaclor in treating urinary infections .

目的：观察新达罗（国产头孢克罗）治疗泌尿系感染的疗效，并与希刻劳（进口头孢克罗）进行比较。

OBJECTIVE : To observe the efficacy of cefaclor in treatment of diabetes combined with acute cystitis .

目的：观察头孢克罗（新达罗）对糖尿病合并急性膀胱炎的疗效。

Application of Anhydrous lactose in Production of Cefaclor Tablets

无水乳糖在头孢克洛片生产中的应用

Methods : 460 children with bacterial respiratory infection were treated with cefaclor taken orally for 7 days .

方法：采用头孢克罗治疗小儿呼吸道细菌性感染460例，7d为一个疗程。

Respiratory Tract Infections : Clinical Observation of Cefprozil Vs Cefaclor

头孢丙烯和头孢克洛治疗呼吸道感染的临床研究

Cefaclor in treatment of oral facial infections

新达罗治疗口腔颌面部感染

Study on Relative Bioavailability of Cefaclor Granules

头孢克罗颗粒剂相对生物利用度研究

60 patients as the control group received cefaclor 0.25 g tid , both for 7 ~ 14 days .

对照组60例，给予头孢克洛片0.25g，tid。疗程均为7～14d。

Randomized double-blind labeled controlled clinical trial on compound cefaclor in treatment of acute infections of respiratory tract

复方头孢克洛胶囊随机双盲对照治疗急性呼吸道感染性疾病临床试验

Dosage regimen of cefaclor based on pharmacokinetic-pharmacodynamic model

基于PK/PD模型的头孢克洛给药方案

Randomized controlled clinical trial of cefuroxime axetil vs cefaclor in treatment of lower respiratory tract infection

头孢呋辛酯与头孢克洛对照治疗下呼吸道感染的疗效观察

Objective To investigate the clinical efficacy of cefixime and cefaclor in the treatment of respiratory tract infection in children .

目的探讨头孢克肟和头孢克洛治疗小儿呼吸道感染的临床疗效。

Clinical efficacy evaluation of cefdinir and cefaclor in the treatment of 51 cases of community aquired pneumonia

头孢地尼与头孢克罗治疗社区获得性肺炎51例疗效比较

Dermato-joint allergic purpura following cefaclor treatment in a child

头孢克洛致小儿皮肤关节型过敏性紫癜

AIM : To study phamacokinetics and bioavailability of cefaclor granules in 10 healthy volunteers .

目的：研究2种头孢克洛颗粒剂在10名健康志愿者体内的生物利用度。

Treatment of broncho lung infections with cefaclor capsules

新达罗胶囊治疗支气管－肺感染108例

OBJECTIVE : To evaluate the relative bioavailability of2kinds of preparations of cefaclor capsules .

目的：评价头孢克罗胶囊2种制剂的生物等效性。